Prostap 3 DCS 11.25mg pdr and solvent for prolonged-rel inj
0803042N0BBADAD · Malignant Disease and Immunosuppression
16,752items
Dispensed in April 2026
NHSBSA Prescription Cost Analysis
£3,792,999
Net ingredient cost · April 2026
NHSBSA PCA
204,001items
Dispensed in the last 12 months
NHSBSA PCA
Figure 1. Prostap 3 DCS 11.25mg pdr and solvent for prolonged-rel inj: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to April 2026
One presentation of Leuprorelin acetate. See the chemical for the full national picture and related presentations.
Top dispensing practices
Dispensing GP practices supplying this presentation, by items (a subset of national dispensing).
| Practice | Items |
|---|---|
| Holderness Health | 417 |
| Mendip Vale Medical Practice | 395 |
| Lakeside Healthcare Stamford | 386 |
| Modality Partnership (awc) | 291 |
| The Ridings Medical Group | 278 |
| Ammonite Health Partnership | 266 |
| Coastal Villages Practice | 245 |
| Rolle Medical Partnership | 242 |
| Abbottswood Medical Centre | 227 |
| Westrop Medical Practice | 212 |